These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 25676325

  • 1. Anti-cancer and anti-hepatitis C virus NS5B polymerase activity of etodolac 1,2,4-triazoles.
    Çıkla-Süzgün P, Kaushik-Basu N, Basu A, Arora P, Talele TT, Durmaz I, Çetin-Atalay R, Küçükgüzel ŞG.
    J Enzyme Inhib Med Chem; 2015; 30(5):778-85. PubMed ID: 25676325
    [Abstract] [Full Text] [Related]

  • 2. Recent advances on the synthesis of hepatitis C virus NS5B RNA-dependent RNA-polymerase inhibitors.
    Zhao C, Wang Y, Ma S.
    Eur J Med Chem; 2015 Sep 18; 102():188-214. PubMed ID: 26276434
    [Abstract] [Full Text] [Related]

  • 3. Novel 4-thiazolidinones as non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA polymerase.
    Çakir G, Küçükgüzel İ, Guhamazumder R, Tatar E, Manvar D, Basu A, Patel BA, Zia J, Talele TT, Kaushik-Basu N.
    Arch Pharm (Weinheim); 2015 Jan 18; 348(1):10-22. PubMed ID: 25449674
    [Abstract] [Full Text] [Related]

  • 4. Synthesis of novel diflunisal hydrazide-hydrazones as anti-hepatitis C virus agents and hepatocellular carcinoma inhibitors.
    Şenkardeş S, Kaushik-Basu N, Durmaz İ, Manvar D, Basu A, Atalay R, Küçükgüzel ŞG.
    Eur J Med Chem; 2016 Jan 27; 108():301-308. PubMed ID: 26695731
    [Abstract] [Full Text] [Related]

  • 5. Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase.
    Manfroni G, Meschini F, Barreca ML, Leyssen P, Samuele A, Iraci N, Sabatini S, Massari S, Maga G, Neyts J, Cecchetti V.
    Bioorg Med Chem; 2012 Jan 15; 20(2):866-76. PubMed ID: 22197397
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and anti-HCV activity evaluation of anilinoquinoline derivatives.
    Peng HK, Lin CK, Yang SY, Tseng CK, Tzeng CC, Lee JC, Yang SC.
    Bioorg Med Chem Lett; 2012 Jan 15; 22(2):1107-10. PubMed ID: 22204909
    [Abstract] [Full Text] [Related]

  • 7. Tetrazole and triazole as bioisosteres of carboxylic acid: discovery of diketo tetrazoles and diketo triazoles as anti-HCV agents.
    Song WH, Liu MM, Zhong DW, Zhu YL, Bosscher M, Zhou L, Ye DY, Yuan ZH.
    Bioorg Med Chem Lett; 2013 Aug 15; 23(16):4528-31. PubMed ID: 23856047
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anti-hepatitis-C virus activity and QSAR study of certain thiazolidinone and thiazolotriazine derivatives as potential NS5B polymerase inhibitors.
    Hassan GS, Georgey HH, Mohammed EZ, Omar FA.
    Eur J Med Chem; 2019 Dec 15; 184():111747. PubMed ID: 31604164
    [Abstract] [Full Text] [Related]

  • 10. Preparation and biological evaluation of 1'-cyano-2'-C-methyl pyrimidine nucleosides as HCV NS5B polymerase inhibitors.
    Mish MR, Cho A, Kirschberg T, Xu J, Zonte CS, Fenaux M, Park Y, Babusis D, Feng JY, Ray AS, Kim CU.
    Bioorg Med Chem Lett; 2014 Jul 15; 24(14):3092-5. PubMed ID: 24907145
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Design and synthesis of lactam-thiophene carboxylic acids as potent hepatitis C virus polymerase inhibitors.
    Barnes-Seeman D, Boiselle C, Capacci-Daniel C, Chopra R, Hoffmaster K, Jones CT, Kato M, Lin K, Ma S, Pan G, Shu L, Wang J, Whiteman L, Xu M, Zheng R, Fu J.
    Bioorg Med Chem Lett; 2014 Aug 15; 24(16):3979-85. PubMed ID: 24986660
    [Abstract] [Full Text] [Related]

  • 13. Structure-based virtual screening, synthesis and SAR of novel inhibitors of hepatitis C virus NS5B polymerase.
    Talele TT, Arora P, Kulkarni SS, Patel MR, Singh S, Chudayeu M, Kaushik-Basu N.
    Bioorg Med Chem; 2010 Jul 01; 18(13):4630-8. PubMed ID: 20627595
    [Abstract] [Full Text] [Related]

  • 14. Novel 1,2,4-triazole and imidazole derivatives of L-ascorbic and imino-ascorbic acid: synthesis, anti-HCV and antitumor activity evaluations.
    Wittine K, Stipković Babić M, Makuc D, Plavec J, Kraljević Pavelić S, Sedić M, Pavelić K, Leyssen P, Neyts J, Balzarini J, Mintas M.
    Bioorg Med Chem; 2012 Jun 01; 20(11):3675-85. PubMed ID: 22555152
    [Abstract] [Full Text] [Related]

  • 15. Multiple e-pharmacophore modeling, 3D-QSAR, and high-throughput virtual screening of hepatitis C virus NS5B polymerase inhibitors.
    Therese PJ, Manvar D, Kondepudi S, Battu MB, Sriram D, Basu A, Yogeeswari P, Kaushik-Basu N.
    J Chem Inf Model; 2014 Feb 24; 54(2):539-52. PubMed ID: 24460140
    [Abstract] [Full Text] [Related]

  • 16. Quinolones as HCV NS5B polymerase inhibitors.
    Kumar DV, Rai R, Brameld KA, Somoza JR, Rajagopalan R, Janc JW, Xia YM, Ton TL, Shaghafi MB, Hu H, Lehoux I, To N, Young WB, Green MJ.
    Bioorg Med Chem Lett; 2011 Jan 01; 21(1):82-7. PubMed ID: 21145235
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Further SAR studies on novel small molecule inhibitors of the hepatitis C (HCV) NS5B polymerase.
    Reddy TJ, Chan L, Turcotte N, Proulx M, Pereira OZ, Das SK, Siddiqui A, Wang W, Poisson C, Yannopoulos CG, Bilimoria D, L'Heureux L, Alaoui HM, Nguyen-Ba N.
    Bioorg Med Chem Lett; 2003 Oct 06; 13(19):3341-4. PubMed ID: 12951122
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and SAR optimization of diketo acid pharmacophore for HCV NS5B polymerase inhibition.
    Bhatt A, Gurukumar KR, Basu A, Patel MR, Kaushik-Basu N, Talele TT.
    Eur J Med Chem; 2011 Oct 06; 46(10):5138-45. PubMed ID: 21893371
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.